Events
Advertisement
Advertisement
Trending on HCPLive
1
ESSENCE: Semaglutide Improves Liver Markers in MASH Without Obesity
2
Lp(a)HORIZON, Oral PCSK9s, and 2027 Lipid Trials, with Kausik Ray, MD, MBChB, MPhil
3
Single Dose of CIDEB siRNA Normalizes Liver Fat in MASLD Through 36 Weeks
4
Elebsiran Plus Tobevibart Suppresses HDV RNA in Phase 3 ECLIPSE 1 Trial
5